Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Feb;75(2):456–461. doi: 10.1172/JCI111720

Plasmin inhibition of platelet function and of arachidonic acid metabolism.

A I Schafer, B Adelman
PMCID: PMC423519  PMID: 3156149

Abstract

To study interactions between platelets and the fibrinolytic system, we examined the effects of human plasmin on human platelets washed by gel filtration. Plasmin concentrations that did not affect platelet shape change, release, or aggregation (less than 1.0 caseinolytic units [CU]/ml) caused a dose- and time-dependent inhibition of platelet aggregation in response to thrombin, ionophore A23187, and collagen. Complete loss of aggregation occurred at 0.1-0.5 CU/ml of plasmin. In a parallel dose-dependent manner, plasmin likewise inhibited thrombin, ionophore, and collagen-stimulated thromboxane B2 production. In contrast, neither aggregation nor thromboxane B2 formation induced by arachidonate was inhibited by plasmin pretreatment of the platelets. Plasmin blocked the thrombin-induced release of [3H]arachidonic acid from platelet membrane phospholipids and the thrombin-induced platelet oxygen burst. However, plasmin did not inhibit the arachidonate-induced oxygen burst. Inhibition of arachidonic acid release by plasmin was not mediated by increase in platelet cyclic AMP. These results suggest that plasmin inhibits platelet function, at least in part, by blocking the mobilization of arachidonic acid from membrane phospholipid pools. The effects of plasmin on platelets may contribute to the hemostatic abnormalities seen in pathologic and pharmacologic fibrinolysis.

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORN G. V., CROSS M. J. THE AGGREGATION OF BLOOD PLATELETS. J Physiol. 1963 Aug;168:178–195. doi: 10.1113/jphysiol.1963.sp007185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bressler N. M., Broekman M. J., Marcus A. J. Concurrent studies of oxygen consumption and aggregation in stimulated human platelets. Blood. 1979 Feb;53(2):167–178. [PubMed] [Google Scholar]
  3. Carroll R. C., Gerrard J. M., Gilliam J. M. Clot retraction facilitates clot lysis. Blood. 1981 Jan;57(1):44–48. [PubMed] [Google Scholar]
  4. Carroll R. C., Radcliffe R. D., Taylor F. B., Jr, Gerrard J. M. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies. J Lab Clin Med. 1982 Dec;100(6):986–996. [PubMed] [Google Scholar]
  5. Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost. 1980 Jun 18;43(2):77–89. [PubMed] [Google Scholar]
  6. Costa J. L., Murphy D. L. Platelet 5-HT uptake and release stopped rapidly by formaldehyde. Nature. 1975 May 29;255(5507):407–408. doi: 10.1038/255407a0. [DOI] [PubMed] [Google Scholar]
  7. Greenberg J. P., Packham M. A., Guccione M. A., Rand M. L., Reimers H. J., Mustard J. F. Survival of rabbit platelets treated in vitro with chymotrypsin, plasmin, trypsin, or neuraminidase. Blood. 1979 May;53(5):916–927. [PubMed] [Google Scholar]
  8. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Imai A., Yano K., Kameyama Y., Nozawa Y. Reversible thrombin-induced modification of positional distribution of fatty acids in platelet phospholipids: involvement of deacylation-reacylation. Biochem Biophys Res Commun. 1981 Dec 15;103(3):1092–1099. doi: 10.1016/0006-291x(81)90920-7. [DOI] [PubMed] [Google Scholar]
  10. Jerushalmy Z., Zucker M. B. Some effects of fibrinogen degradation products (FDP) on blood platelets. Thromb Diath Haemorrh. 1966 May 15;15(3):413–419. [PubMed] [Google Scholar]
  11. Lapetina E. G., Schmitges C. J., Chandrabose K., Cuatrecases P. Cyclic adenosine 3',5'-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets. Biochem Biophys Res Commun. 1977 Jun 6;76(3):828–835. doi: 10.1016/0006-291x(77)91575-3. [DOI] [PubMed] [Google Scholar]
  12. Lockhart M. S., Comp P. C., Taylor F. B., Jr Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets. J Lab Clin Med. 1979 Aug;94(2):285–294. [PubMed] [Google Scholar]
  13. Malmsten C., Kindahl H., Samuelsson B., Levy-Toledano S., Tobelem G., Caen J. P. Thromboxane synthesis and the platelet release reaction in Bernard-Soulier syndrome, thrombasthenia Glanzmann and Hermansky-Pudlak syndrome. Br J Haematol. 1977 Apr;35(4):511–520. doi: 10.1111/j.1365-2141.1977.tb00617.x. [DOI] [PubMed] [Google Scholar]
  14. Marcus A. J. Pathways of oxygen utilization by stimulated platelets and leukocytes. Semin Hematol. 1979 Jul;16(3):188–195. [PubMed] [Google Scholar]
  15. Miller J. L., Katz A. J., Feinstein M. B. Plasmin inhibition of thrombin-induced platelet aggregation. Thromb Diath Haemorrh. 1975 Apr 30;33(2):286–309. [PubMed] [Google Scholar]
  16. Minkes M., Stanford N., Chi M. M., Roth G. J., Raz A., Needleman P., Majerus P. W. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. J Clin Invest. 1977 Mar;59(3):449–454. doi: 10.1172/JCI108659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mürer E. H. Release reaction and energy metabolism in blood platelets with special reference to the burst in oxygen uptake. Biochim Biophys Acta. 1968 Oct 1;162(3):320–326. doi: 10.1016/0005-2728(68)90118-7. [DOI] [PubMed] [Google Scholar]
  18. Niewiarowski S., Senyi A. F., Gillies P. Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis. J Clin Invest. 1973 Jul;52(7):1647–1659. doi: 10.1172/JCI107345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Prescott S. M., Majerus P. W. The fatty acid composition of phosphatidylinositol from thrombin-stimulated human platelets. J Biol Chem. 1981 Jan 25;256(2):579–582. [PubMed] [Google Scholar]
  20. Reimers H. J., Scharf R. E., Baker R. K. Thrombin pretreatment of human platelets impairs thromboxane A2 synthesis from endogenous precursors in the presence of normal cyclooxygenase activity. Blood. 1984 Apr;63(4):858–865. [PubMed] [Google Scholar]
  21. Rittenhouse-Simmons S. Differential activation of platelet phospholipases by thrombin and ionophore A23187. J Biol Chem. 1981 May 10;256(9):4153–4155. [PubMed] [Google Scholar]
  22. Rittenhouse-Simmons S., Russell R. A., Deykin D. Transfer of arachidonic acid to human platelet plasmalogen in response to thrombin. Biochem Biophys Res Commun. 1976 May 3;70(1):295–301. doi: 10.1016/0006-291x(76)91141-4. [DOI] [PubMed] [Google Scholar]
  23. SGOURIS J. T., INMAN J. K., McCALL K. B., HYNDMAN L. A., ANDERSON H. D. The preparation of human fibrinolysin (plasmin). Vox Sang. 1960 Jul;5:357–376. doi: 10.1111/j.1423-0410.1960.tb03750.x. [DOI] [PubMed] [Google Scholar]
  24. Taylor F. B., Jr, Müller-Eberhard H. J. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets. J Clin Invest. 1970 Nov;49(11):2068–2085. doi: 10.1172/JCI106425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Teger-Nilsson A. C., Friberger P., Gyzander E. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest. 1977 Sep;37(5):403–409. [PubMed] [Google Scholar]
  26. VanRollins M., Ho S. H., Greenwald J. E., Alexander M., Dorman N. J., Wong L. K., Horrocks L. A. Complete separation by high performance liquid chromatography of metabolites of arachidonic acid from incubation with human and rabbit platelets. Prostaglandins. 1980 Sep;20(3):571–577. doi: 10.1016/0090-6980(80)90044-1. [DOI] [PubMed] [Google Scholar]
  27. Vermylen J., Badenhorst P. N., Deckmyn H., Arnout J. Normal mechanisms of platelet function. Clin Haematol. 1983 Feb;12(1):107–151. [PubMed] [Google Scholar]
  28. Verstraete M., Vermylen J., Schetz J. Biochemical changes noted during intermittent administration of streptokinase. Thromb Haemost. 1978 Feb 28;39(1):61–68. [PubMed] [Google Scholar]
  29. Wiman B., Collen D. Molecular mechanism of physiological fibrinolysis. Nature. 1978 Apr 6;272(5653):549–550. doi: 10.1038/272549a0. [DOI] [PubMed] [Google Scholar]
  30. Winocour P. D., Kinlough-Rathbone R. L., Richardson M., Mustard J. F. Reversal of shortened platelet survival in rats by the antifibrinolytic agent, epsilon aminocaproic acid. J Clin Invest. 1983 Jan;71(1):159–164. doi: 10.1172/JCI110745. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES